Organization Overview
Historical Acquisition Tree
Alternative names
antihemophilic factor viii (Recombinant) (Adynovate) (2015)
blood plasma (2013 NDA)
Key: Octapharma (1) Acquired (6)
Afibrinogenemia (Phase 3)
Agammaglobulinemia (Phase 3)
alpha 1-Antitrypsin Deficiency (Phase 2)
Alzheimer Disease (Phase 2)
Aneurysm (Phase 4)
Antithrombin III Deficiency (Phase 4)
Aortic Aneurysm (Phase 4)
Aortic Aneurysm, Thoracic (Phase 4)
Dermatomyositis (Phase 3)
Disease Progression (Phase 3)
Encephalitis (Phase 3)
Hemophilia A (Phase 3)
Hemorrhage (Phase 4)
Immunologic Deficiency Syndromes (Phase 4)
Infections (Phase 4)
Inflammation (Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Liver Diseases (Phase 4)
Peripheral Nervous System Diseases (Phase 3)
Polyradiculoneuropathy (Phase 3)
Pre-Eclampsia (Phase 4)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 4)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Shock (Phase 4)
Shock, Septic (Phase 4)
Streptococcal Infections (Phase 4)
Syndrome (Phase 4)
Thrombocytopenia (Phase 4)
von Willebrand Diseases (Phase 3)